Table 4.
Mean dose to CTV expressed in EQD2 and CTV volume, for all tumours and tumours stratified according to best response
| Mean dose in EQD2 (Gy) | CTV (cm3) | |
|---|---|---|
| All tumours a (n = 134/136) | ||
| Mean (std) | 194.5 (84.5) | 60.2 (138.3) |
| Median (range) | 181.1 (39.0–402.8) | 11.4 (0.0–864.2) |
| Tumours with best response CR a (n = 38/39) | ||
| Mean (std) | 213.0 (83.6) | 72.9 (153.6) |
| Median (range) | 204.4 (53.3–392.1) | 5.9 (0.0–594.1) |
| Tumours with best response PR (n = 27) | ||
| Mean (std) | 174.4 (86.7) | 55.5 (137.0) |
| Median (range) | 156.7 (48.8–361.3) | 10.6 (0.3–711.7) |
| Tumours with best response SD (n = 53) | ||
| Mean (std) | 205.8 (83.1) | 45.1 (121.8) |
| Median (range) | 192.6 (40.5–402.8) | 9.5 (0.0–864.2) |
| Tumours with best response PD (n = 16) | ||
| Mean (std) | 147.1 (68.4) | 88.0 (159.5) |
| Median (range) | 147.5 (39.0–293.7) | 23.0 (2.4–559.7) |
aFor one tumour, information about response was not available; for another (responding with CR), information about fractionation schedule was not available and mean dose could not be calculated